{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-269416","form_type":"8-K","ticker":null,"cik":"0001800682","company_name":"Cano Health, Inc.","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.516311+00:00","generated_at":"2026-06-09T00:47:40.223435+00:00","sec_items":["3.03","5.03","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cano Health completes 1-for-100 reverse stock split to regain NYSE compliance","bullets":["Stockholders approved split at Nov 2 special meeting: 316M for, 19.6M against.","Effective Nov 2; trading on split-adjusted basis begins Nov 3 on NYSE under CANO.","Post-split shares: ~2.9M Class A and ~2.5M Class B common stock outstanding.","Authorized shares cut from 6B to 60M Class A and from 1B to 10M Class B.","Warrants adjusted: 100 warrants now exercise for one share at $1,150; redeemable."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-269416","json":"https://secwatch.observer/filing/0001193125-23-269416.json","markdown":"https://secwatch.observer/filing/0001193125-23-269416.md","text":"https://secwatch.observer/filing/0001193125-23-269416.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800682/000119312523269416/0001193125-23-269416-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800682/000119312523269416/d563503d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T00:47:40.223435+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9c77dd2f49888d089e2276d5a11e1b2ee9671b1a","claim":"Cano Health, Inc.: Filed Certificate of Amendment to effect a 1-for-100 reverse stock split of Class A and Class B common stock (effective 2023-11-02).","evidence_excerpt":"On November 2, 2023, Cano Health, Inc. (“ Cano Health ” or the “ Company ”) issued a press release (the “ Press Release ”) announcing, among other things, that it has filed a Certificate of Amendment (the “ Certificate of Amendment ”) to its Certificate of Incorporation with the Delaware Secretary of State to effect the 1-for-100 reverse stock split (the “ Reverse Stock Split ”) of shares of its Class A and Class B common stock, each previously $0.0001 par value per share (together, the “ Common Stock ”). The Certificate of Amendment became effective immediately upon filing on November 2, 2023 (the “ Effective Time ”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1800682/000119312523269416/0001193125-23-269416-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-11-02"}],"fact_type":"governance_change"},{"claim_id":"e3d0f883e02ae713b8642316b0093b5db389a149","claim":"Cano Health, Inc. shareholders approved a proposal to grant the Company’s Board of Directors the discretionary authority to amend the Company’s Certificate of Incorporation to effect a reverse stock split of the authorized shares of the Company’s Common Stock, including both issued and outstanding and unissued shares, at a ratio of 1-for- at the 2023-11-02 meeting.","evidence_excerpt":"On November 2, 2023, the Company held a special stockholders’ meeting (the “ Special Meeting ”). At the Special Meeting, the Company’s stockholders approved a proposal to grant the Company’s Board of Directors the discretionary authority to amend the Company’s Certificate of Incorporation to effect a reverse stock split of the authorized shares of the Company’s Common Stock, including both issued and outstanding and unissued shares, at a ratio of 1-for-60, with the Board having the right to adjust such ratio, acting in its sole discretion and in the Company’s best interest, down to 1-for-5 and up to 1-for-100, inclusive, such exact ratio to be determined at any time prior to November 2, 2024 (the “ Reverse Stock Split Proposal ”). A total of 336,931,904 shares of the Company’s Common Stock were present at the Special Meeting in person or by proxy, which represented approximately 62% of the outstanding shares of the Company’s Common Stock as of October 5, 2023, the record date for the S","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1800682/000119312523269416/0001193125-23-269416-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-02"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}